Vaccine R&D pipeline/IP review is a comprehensive database which allows effective monitoring of the fasting moving vaccine R&D pipeline. The database contains around 450 validated entries of active commercial vaccine programs covering over 80 companies. It can be used for competitive intelligence, business development and strategic planning activities. The database is updated on a continuous basis.
*****NEW FOR OCTOBER 2009**** Clients can now register for free on-line "standard" database or sign up to "premium" version with added features/functionality. Please see below for database comparison.
**Prices quotes are for 1 username/password only for premium database version for six months access. Vaccine program status (clinical development Phase) is updated continuously. Preclinical and IP fields; every six months. For UK orders VAT will be added at 15.0%. Please review the TERMS and CONDITIONS of purchase.